Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2262-2266

  Henry, D ^a   Ellison, W ^b   Sullivan, J ^e   Mansfield, D L ^c   Magner, D J ^c,d   Dorr, M B ^c   Talbot, G H ^c  

^a Foothill Family Clinic   (United States)

^b Medquest   (United States)

^c SANOFI   (France)

^d Astra Merck   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

OFLOXACIN; SPARFLOXACIN;

ADULT; ARTICLE; BACTERIOLOGY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHOTOSENSITIVITY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; STAPHYLOCOCCUS SAPROPHYTICUS; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION;

EID: 0031658258     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2262     Document Type: Article

References (31)

1. Chin, N.-X., J.-W. Gu, K.-W. Yu, Y.-X. Zhang, and H. C. Neu. 1991. In vitro activity of sparfloxacin. Antimicrob. Agents Chemother. 35:567-571.
2. Elder, N. C. 1992. Acute urinary tract infection in women. Postgrad. Med. 92:159-162, 165-166, 172.
3. Fish, D. N., S. C. Piscitelli, and L. H. Danziger. 1995. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 15:279-291.
4. Hatton, J., M. Hughes, and C. H. Raymond. 1994. Management of bacterial urinary tract infections in adults. Ann. Pharmacother. 28:1264-1272.
5. Hooten, T. M., C. Johnson, C. Winter, L. Kuwamura, M. E. Rogers, P. L. Roberts, and W. E. Stamm. 1991. Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob. Agents Chemother. 35:1479-1483.
6. Hooten, T. M., R. H. Latham, E. S. Wong, C. Johnson, P. L. Roberts, and W. E. Stamm. 1991. Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob. Agents Chemother. 33:1308-1312.
7. Iravani, A. 1991. Treatment of uncomplicated urinary tract infections with temafloxacin. Am. J. Med. 9(Suppl. 6A):124S-128S.
8. Iravani, A. 1991. Advances in the understanding and treatment of urinary tract infections in young women. Urology 37:503-511.
9. Iravani, A. 1993. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am. J. Med. 94(Suppl. 3A):89S-96S.
10. Iravani, A., A. D. Tice, J. McCarty, D. H. Sikes, T. Nolen, H. A. Gallis, E. P. Whalen, et al. 1995. Short-course ciproflox treatment of acute uncomplicated urinary tract infection in women. Arch. Intern. Med. 155:485-494.
11. Jaillon, P., J. Morganroth, I. Brumpt, G. Talbot, et al. 1996. Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. J. Antimicrob. Chemother. 37(Suppl. A):161-167.
12. Masterson, R. G., and J. A. Bochsler. 1995. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J. Antimicrob. Chemother. 35:129-137.
13. McNeil Pharmaceutical. 1996. Floxin, p. 1567-1571. In Physician's desk reference, 1996 ed. Medical Economics Co., Inc., Montvale, N.J.
14. Montay, G. 1996. Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review. J. Antimicrob. Chemother. 37(Suppl. A):27-39.
15. Naber, K. G., F. Di Silverio, A. Geddes, and J. Guilbert. 1996. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. J. Antimicrob. Chemother. 37(Suppl. A):135-144.
16. Nakamura, S., A. Minami, K. Nakata, N. Kurobe, K. Kouno, Y. Sakaguchi, S. Kashimoto, H. Yoshida, T. Kojima, T. Ohue, K. Fujimoto, M. Nakamura, M. Hashimoto, and M. Shimizu. 1989. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. Antimicrob. Agents Chemother. 33:1167-1173.
17. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard. Document M2-A5, vol. 13, no. 24. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard. Document M7-A3, vol. 13, no. 25. National Committee for Clinical Laboratory Standards, Wayne, Pa.
19. Neringer, R., A. Forsgren, C. Hansson, B. Ode, and the South Swedish LOLEX Study Group. 1992. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. Scand. J. Infect. Dis. 24:773-780.
20. Nicolle, L. E., J. DuBois, A. Y. Martel, G. K. M. Harding, S. D. Shafran, and J. M. Conly. 1993. Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. Antimicrob. Agents Chemother. 37:574-579.
21. Norrby, S. R. 1990. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev. Infect. Dis. 12:458-467.
22. Paradelis, A. G., K. Delidou, A. Grigoriadou, G. Salpigides, and A. Pangalis. 1995. The antimicrobial activity of sparfloxacin, a new quinolone. Drugs 49 (Suppl. 2):238-239.
23. Patron, C., F. Baquero, J.-L. Montcagudo, and M.-F. Vincente. 1991. Post-antibiotic effect of sparfloxacin. Eur. J. Clin. Microbiol. Infect. Dis. Special Issue 1991:537-540.
24. Raz, R., E. Rottensterich, Y. Leshem, and H. Tabenkin. 1994. Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women. Antimicrob. Agents Chemother. 38:1176-1177.
25. Rhône-Poulenc Rorer. Data on file.
26. Rubinstein, E. 1996. Safety profile of sparfloxacin in the treatment of respiratory tract infections. J. Antimicrob. Chemother. 37(Suppl. A):145-160.
27. Stamm, W. E., and T. M. Hooten. 1993. Management of urinary tract infections in adults. N. Engl. J. Med. 329:1328-1334.
28. Stein, G. E., and E. Philip. 1992. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women. J. Fam. Pract. 34:180-184.
29. von Rosensteil, N., and D. Adam. 1994. Quinolone antibacterials. An update of their pharmacology and therapeutic use. Drugs 47:872-901.
30. Ward, T. T., and S. R. Jones. 1991. Genitourinary tract infections, p. 257-275. In R. E. Reese and R. F. Betts (ed.), A practical approach to infectious disease, 3rd ed. Little, Brown & Co., Boston, Mass.
31. Williams, D. N. 1996. Urinary tract infections. Postgrad. Med. 99:189-192, 198-199, 201, 204.